What You Need to Know About the Bundibugyo Virus: A New Variant of ebola.

Published: May 18, 2026.

A new public health emergency is unfolding in Central Africa. The World Health Organization (WHO) has officially declared a Public Health Emergency of International Concern (PHEIC) regarding the latest Ebola outbreak. Unlike previous crises, this one involves a rare variant of the Ebola virus for which there are currently no licensed vaccines or specific treatments.

Here is the latest information on the situation, the risks, and why this strain is different.

Why This Outbreak is Different: The Bundibugyo Strain

When most people hear "Ebola," they think of the Zaire strain—the highly aggressive virus responsible for the devastating West Africa epidemic. However, the current outbreak, declared on May 15, 2026, in the Democratic Republic of the Congo (DRC), is caused by the Bundibugyo virus (BDBV) .

WHO Declares DRC Ebola Outbreak a Public Health Emergency of International Concern

This is only the third time this specific variant has been detected since it was first identified in Uganda in 2007.

Key Differences at a Glance:

· Mortality Rate: While Zaire Ebola can kill up to 80-90% of those infected, the Bundibugyo strain historically has a lower (though still severe) fatality rate ranging from 30% to 50% .

· No Medical Countermeasures: Current FDA-approved treatments (like Inmazeb and Ebanga) and vaccines (like Ervebo) are specifically designed for the Zaire strain. They do not currently work for Bundibugyo.

BBC news report

· Symptoms: The illness still presents with fever, fatigue, and bleeding, but the hemorrhagic signs may appear later than usual, which can delay detection.

Current Situation: Cases, Location, and WHO Response

As of May 17, 2026, health authorities have reported a rapidly escalating number of cases.

· Location: The epicenter is in the Ituri Province of eastern DRC, a region already struggling with conflict and displacement. The virus has spread to the provincial capital, Bunia, and has crossed borders.

Ebola Crisis: Africa CDC Reports 246 Cases as Deadly Outbreak Strikes DRC

· Uganda: Uganda has confirmed imported cases involving travelers from the DRC, including a death in the capital city of Kampala.

· Casualty Count: Initial reports indicate at least 336 suspected cases and 88 deaths. However, given the detection lag in remote areas, these numbers are expected to rise.

The WHO Director-General determined on May 16 that this constitutes a PHEIC—the highest alert level—due to the high risk of regional spread and the lack of a vaccine.

The Challenge: Conflict, Mobility, and Healthcare Access

Stopping this virus is proving difficult due to factors outside of biology.

· Insecurity: The eastern DRC is a conflict zone. Ongoing violence restricts the movement of rapid response teams, making it dangerous to track contacts or safely bury the dead.

· Healthcare Worker Risk: At least four health workers have already died, indicating significant breaches in infection prevention and control (IPC) protocols in local clinics.

· Population Movement: The affected zones are mining areas with high mobility. People moving between DRC, Uganda, and South Sudan raise the risk of the virus spreading to major cities.

Is There Hope for Treatment?

While there is no silver bullet yet, the scientific community is mobilizing.

Researchers are exploring broad-spectrum antivirals—drugs designed to attack the parts of the virus that don't mutate as much. One candidate, NV-387, mimics proteins that filoviruses use to attach to human cells, potentially working against multiple strains.

Additionally, African health agencies are planning to test existing Zaire vaccines for "cross-protection," though early tests suggest effectiveness may only be around 50%.

What is the Risk to the General Public?

For those living outside Central Africa, the risk remains extremely low. Ebola does not spread through the air. It requires direct contact with the blood, vomit, or bodily fluids of a symptomatic person or contaminated materials.

The U.S. CDC has stated that the risk to the American public is low. However, the situation highlights the need for robust global surveillance to prevent isolated outbreaks from becoming pandemics.

Summary

The 2026 Ebola outbreak is a stark reminder that the fight against viral hemorrhagic fevers is not over. The emergence of the Bundibugyo strain without a vaccine underscores the urgent need for broad-spectrum antiviral research and strengthening healthcare systems in conflict zones.

We will continue to update this page as new information becomes available.

Disclaimer: This article is for informational purposes based on data available as of May 18, 2026. Always refer to the WHO and local health authorities for the most current travel advisories.